pyrroles has been researched along with Glomerulosclerosis, Focal Segmental in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukahori, H; Hanaoka, K; Hirose, J; Inami, M; Ito, M; Kaneko, Y; Kawato, Y; Kubo, K; Maeda, M; Morokata, T; Nakamura, K; Nakanishi, T; Noto, T | 1 |
| Costero, O; Martinez-Ara, J; Picazo, ML; Romero, S; Selgas, R; Zamora, P | 1 |
| Aoyama, T; Bando, T; Fukuda, N; Katakawa, M; Matsuda, H; Matsui, S; Matsumoto, K; Matsumoto, Y; Nagase, H; Saito, K; Sugiyama, H; Ueno, T; Wang, X; Watanabe, T | 1 |
| Gassman, J; Gipson, D; Greene, T; Joy, M; Pinsk, M; Savin, V; Somers, M; Trachtman, H; Vento, S; Wickman, L | 1 |
| Arias, SC; Camara, NO; Fanelli, C; Fujihara, CK; Kuriki, PS; Machado, FG; Malheiros, DM; Zatz, R | 1 |
| Blanco, S; Egido, J; Gómez-Guerrero, C; López, D; Romero, R; Vaquero, M | 1 |
| Aragoncillo, P; Cachofeiro, V; Cediel, E; de Las Heras, N; Díaz, C; Hernández, G; Lahera, V; Navarro-Cid, J; Ruilope, LM; Sanz-Rosa, D; Vázquez-Pérez, S | 1 |
| Cheung, GT; Frohlich, J; Lynn, EG; O, K; Siow, YL | 1 |
1 trial(s) available for pyrroles and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design.
Topics: Adalimumab; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Galactose; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Humans; Infant; Lisinopril; Losartan; Middle Aged; Pyrroles; Treatment Outcome; Young Adult | 2011 |
7 other study(ies) available for pyrroles and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
Topics: Allografts; Animals; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Interleukin-6; Janus Kinases; Kidney Transplantation; Piperidines; Pyrroles; Rats; Rats, Inbred Lew; Tacrolimus | 2018 |
Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.
Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Renal Cell; Enalapril; Glomerulosclerosis, Focal Segmental; Humans; Indoles; Kidney; Kidney Neoplasms; Lung Neoplasms; Male; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Thrombotic Microangiopathies | 2010 |
Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
Topics: Amino Acids; Animals; Fibrosis; Gene Expression Regulation; Gene Silencing; Genetic Therapy; Glomerulosclerosis, Focal Segmental; Imidazoles; Kidney Glomerulus; Male; Nylons; Promoter Regions, Genetic; Pyrroles; Rats; Rats, Inbred Dahl; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta1 | 2011 |
Chronic VEGF blockade worsens glomerular injury in the remnant kidney model.
Topics: Animals; Catheter Ablation; Glomerulosclerosis, Focal Segmental; Indoles; Kidney Diseases; Kidney Glomerulus; Male; Pyrroles; Rats; Rats, Wistar; Sunitinib; Vascular Endothelial Growth Factor A | 2012 |
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunoenzyme Techniques; Kidney; Kidney Glomerulus; Linear Models; Microscopy, Electron; Obesity; Pyrroles; Quinapril; Rats; Rats, Zucker; Staining and Labeling; Tetrahydroisoquinolines | 2005 |
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
Topics: Acetylcholine; Animals; Anticholesteremic Agents; Atorvastatin; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol, Dietary; Disease Models, Animal; Endothelium, Vascular; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hypercholesterolemia; Kidney; Male; Nitroprusside; Oxazoles; Phenylephrine; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Renal Circulation; Vasodilation | 2001 |
Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
Topics: Amino Acid Sequence; Animals; Calcium Channel Blockers; Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Cholesterol; Diglycerides; Diltiazem; Enzyme Inhibitors; Foam Cells; Gene Expression; Genes, Recessive; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Indoles; Lecithin Cholesterol Acyltransferase Deficiency; Lipoprotein-X; Male; Molecular Sequence Data; Monocytes; NF-kappa B; Phosphatidylcholines; Protein Kinase C; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staurosporine; Type C Phospholipases | 2001 |